As prevalence of obesity continues to rise in the United States, we are beginning to elucidate the complex role of obesity-associated chronic inflammation, endocrine dysfunction, and hormone production as a driver for increased breast cancer risk. Epidemiological data suggest that obesity (BMI > 30) is associated with increased breast cancer incidence, worse prognosis, and higher mortality rates. Mechanistically, obesity and excess fat mass represent a state of chronic inflammation, insulin resistance, adipokine imbalance, and increased estrogen signaling. This pro-tumorigenic environment stimulates cancer development through abnormal growth, proliferation, and survival of mammary tissue. Importantly, obesity is a modifiable risk factor; alterations in cell proliferation, apoptosis, circulating estrogen, and insulin sensitivity are observed in response to weight loss attainable through behavior modification including dietary and exercise changes.
Keyphrases
- insulin resistance
- weight loss
- metabolic syndrome
- high fat diet induced
- weight gain
- type diabetes
- adipose tissue
- bariatric surgery
- risk factors
- oxidative stress
- skeletal muscle
- high fat diet
- cell proliferation
- roux en y gastric bypass
- polycystic ovary syndrome
- body mass index
- squamous cell carcinoma
- breast cancer risk
- gastric bypass
- physical activity
- signaling pathway
- coronary artery disease
- cell death
- glycemic control
- cell cycle arrest
- high intensity
- endoplasmic reticulum stress
- cardiovascular events
- body composition
- estrogen receptor
- papillary thyroid
- squamous cell
- data analysis
- anti inflammatory